JPRN-jRCT1080221127未知4 期
An Open Label, Non-comparative Observational Study to Evaluate the Efficacy and Safety of Olmesartan Medoxomil Tablet 20mg in the Treatment of Mild to Moderate Essential Hypertension for 24 Weeks in Chinese Patients & a Sub-group of ABPM Study to Measure the T/P Ratio and Ambulatory Blood Pressure Change
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 300 人开始时间: 2010年6月10日最近更新:
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •90<=SeDBP<110mmHg, SeSBP<180mmHg
排除标准
- 未提供
研究者
相似试验
尚未招募
4 期
Pulmonary Artery Remodelling With BosentaHypertension, PulmonaryCardiovascular - HypertensionACTRN12606000289516Actelion Phrmaceuticals Australia15
进行中（未招募）
不适用
A Prospective, open-label, non-comparative study to assess the Safety, Tolerability and Efficacy of Voriconazole for the Primary and salvage treatment of Invasive Candidiasis, candidemia and esophageal candiidiasis in pediatric subjects.EUCTR2009-012848-16-CZPfizer Inc.96
进行中（未招募）
不适用
A PROSPECTIVE, OPEN-LABEL, NON-COMPARATIVE STUDY TO ASSESS THE SAFETY, TOLERABILITY AND EFFICACY OF VORICONAZOLE FOR THE PRIMARY AND SALVAGE TREATMENT OF INVASIVE CANDIDIASIS, CANDIDEMIA, AND ESOPHAGEAL CANDIDIASIS IN PEDIATRIC SUBJECTSInvasive candidiasis, including candidemia (ICC), and esophageal candidiasis (EC)MedDRA version: 12.0Level: LLTClassification code 10007161Term: Candidiasis of the esophagusMedDRA version: 12.0Level: LLTClassification code 10060573Term: CandidemiaMedDRA version: 12.0Level: LLTClassification code 10064954Term: Invasive candidiasisEUCTR2009-012848-16-HUPfizer Inc., 235 East 42nd Street, New York, NY 1001796
进行中（未招募）
不适用
A Prospective, open-label, non-comparative study to assess the Safety,Tolerability and Efficacy of Voriconazole for the Primary and salvagetreatment of Invasive Candidiasis, candidemia and esophageal candiidiasisin pediatric subjects.Invasive candidiasis, including candidemia (ICC), and esophageal candidiasis (EC)MedDRA version: 14.1Level: LLTClassification code 10060573Term: CandidemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10064954Term: Invasive candidiasisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10007161Term: Candidiasis of the esophagusSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-012848-16-DEPfizer Inc., 235 East 42nd Street, New York, NY 10017, USA96
进行中（未招募）
1 期
A PROSPECTIVE, OPEN-LABEL, NON-COMPARATIVE STUDY TO ASSESS THE SAFETY, TOLERABILITY AND EFFICACY OF VORICONAZOLE FOR THE PRIMARY AND SALVAGE TREATMENT OF INVASIVE CANDIDIASIS, CANDIDEMIA, AND ESOPHAGEAL CANDIDIASIS IN PEDIATRIC SUBJECTSEUCTR2009-012848-16-SKPfizer Inc., 235 East 42nd Street, New York, NY 1001796